Clinical study of 42 patients treated with ceftazidime
Farci, G.; Laconi, R.; Lai, M.E.; Balestrieri, A.
La Clinica Terapeutica 115(3): 169-172
1985
ISSN/ISBN: 0009-9074 PMID: 3910330 Document Number: 256073
Document emailed within 1 workday
Related Documents
Izumikawa, K.; Hashiguchi, K.; Sawai, T.; Inoue, Y.; Imamura, Y.; Seki, M.; Kakeya, H.; Yamamoto, Y.; Yanagihara, K.; Kohno, S. 2009: Study on the blood concentration and clinical efficacy of ceftazidime, a cephem antibiotic at dose of one gram q.i.d, for adult hospital-acquired pneumonia patients Japanese Journal of Antibiotics 62(1): 9-16Montagnani, M.; Bianchini, C.; Nami, R.; Pavese, G.; Papini, L.; Gennari, C. 1985: Clinical evaluation of ceftazidime in high risk patients International Journal of Clinical Pharmacology Therapy and Toxicology 23(7): 376-383
Aguirrebengoa, L.; Montejo, M.; Urkijo, J.C.; Pérez-Escajadillo, J.; Hernández-Almaraz, J.L.; Aguirre, C. 1989: Usefulness of ceftazidime and imipenem for the treatment of Pseudomonas aeruginosa meningitis. Study of 3 patients Enfermedades Infecciosas y Microbiologia Clinica 7(4): 224-225
Pruekprasert, P.; Tunyapanit, W. 2005: In vitro activity of fosfomycin-gentamicin, fosfomycin-ceftazidime, fosfomycin-imipenem and ceftazidime-gentamicin combinations against ceftazidime-resistant Pseudomonas aeruginosa Southeast Asian Journal of Tropical Medicine and Public Health 36(5): 1239-1242
De la Cámara, R.; Figuera, A.; Sureda, A.; Hermida, G.; Verge, G.; Olalla, I.; Fernández Rañada, J.M.; Domingo Albos, A. 1997: Meropenem versus ceftazidime plus amikacin in the treatment of febrile episodes in neutropenic patients: a randomized study Haematologica 82(6): 668-675
Gibson, J.; Johnson, L.; Snowdon, L.; Joshua, D.; Young, G.; MacLeod, C.; Iland, H.; Vincent, P.; Kronenberg, H. 1994: A randomised dosage study of ceftazidime with single daily tobramycin for the empirical management of febrile neutropenia in patients with hematological diseases International Journal of Hematology 60(2): 119-127
Mimoz, O.; Jacolot, A.; Leotard, S.; Hidri, N.; Samii, K.; Nordmann, P.; Petitjean, O. 1998: Efficacies of cefepime, ceftazidime, and imipenem alone or in combination with amikacin in rats with experimental pneumonia due to ceftazidime-susceptible or -resistant Enterobacter cloacae strains Antimicrobial Agents and ChemoTherapy 42(12): 3304-3308
Rikitake, O.; Nakashima, Y.; Kamei, H.; Motooka, T.; Ibaraki, K.; Naito, S.; Arakawa, K. 1983: Clinical study of 143 patients treated at the kidney center in the Fukuoka University Hospital Nihon Jinzo Gakkai Shi 25(1): 113-119
Nan, Z.; Guoliang, J.; Zhongyin, W. 2015: Clinical symptoms and temporomandibular joint disc deformity study of Wilkes IIi stage patients treated with arthrocentesis Hua Xi Kou Qiang Yi Xue Za Zhi 33(6): 585-588
Keiser, G. 1974: Co-operative study of patients treated with thiamphenicol. Comparative study of patients treated with chloramphenicol and thiamphenicol Postgraduate Medical Journal 50(Suppl 5): 143-145
Hoshina, H.; Mikuni, K.; Ichihashi, H. 1984: Clinical studies of ceftazidime in the pediatric field Japanese Journal of Antibiotics 37(3): 460-468
Tateno, M. 1983: Clinical use of ceftazidime in the field of obstetrics and gynaecology Japanese Journal of Antibiotics 36(12): 3507-3516
Cho, N.; Fukunaga, K.; Kunii, K. 1986: Pharmacokinetic and clinical studies of ceftazidime in perinatal period Japanese Journal of Antibiotics 39(8): 2225-2246
Shintani, M.; Takashima, K.; Kosakai, H.; Takayama, T.; Nakanishi, A.; Shimamoto, I.; Ichijo, M. 1984: Fundamental and clinical studies of ceftazidime in the field of obstetrics and gynecology Japanese Journal of Antibiotics 37(1): 28-32
Sato, Y.; Iwata, S.; Kusumoto, Y.; Shiro, H.; Oikawa, T.; Osano, M. 1986: Fundamental and clinical evaluation of ceftazidime in neonates and premature infants Japanese Journal of Antibiotics 39(8): 2084-2096
Toyonaga, Y.; Sugita, M.; Nakamura, H.; Kawamura, K.; Seo, K.; Takahashi, T.; Hori, M. 1986: Fundamental and clinical studies on ceftazidime in neonates and premature infants Japanese Journal of Antibiotics 39(8): 2121-2141
Lechi, A.; Arosio, E.; Montesi, G.; Vaona, B.; Ghidini, O.; Parrinello, E. 1986: Ceftazidime in patients with severe Pseudomonas infections International Journal of Clinical Pharmacology Therapy and Toxicology 24(3): 159-164
Grundeken, M.J.; Lu, H.; Vos, N.; IJsselmuiden, A.; van Geuns, R-Jan.; Wessely, R.; Dengler, T.; La Manna, A.; Silvain, J.; Montalescot, G.; Spaargaren, Ré.; Tijssen, J.G.P.; de Winter, R.J.; Wykrzykowska, J.J.; Amoroso, G.; Koch, K.T. 2017: One-Year Clinical Outcomes of Patients Presenting With ST-Segment Elevation Myocardial Infarction Caused by Bifurcation Culprit Lesions Treated With the Stentys Self-Apposing Coronary Stent: Results From the APPOSITION III Study Journal of Invasive Cardiology 29(8): 253-258
Xerri, L.; Broggio, R. 1985: Study on the antibacterial activity of ceftazidime in an in vitro pharmacokinetic model Drugs under Experimental and Clinical Research 11(1): 49-54
Lundgren, J.D.; Phillips, A.N.; Pedersen, C.; Clumeck, N.; Gatell, J.M.; Johnson, A.M.; Ledergerber, B.; Vella, S.; Nielsen, J.O. 1994: Comparison of long-term prognosis of patients with AIDS treated and not treated with zidovudine. AIDS in Europe Study Group JAMA 271(14): 1088-1092